Episodic Migraine Research Study
Feel Like Life Is Just One Big Migraine?
NOW ENROLLING FOR A LOCAL INVESTIGATIONAL STUDY
We're looking for adults
that suffer with up to
14 migraine attacks per month.
A member of our staff will be in contact with you shortly.
Do you feel like migraines run your life?
We are searching for Springfield area participants for a clinical study researching options for individuals that struggle with episodic migraines. The goal of this study is to assess the effect of a drug on patients that suffer from these types of migraines. If you suffer from up to 14 migraine attacks per month and if you are looking for a potential treatment option, then we ask for your help in researching this possibility!
WHAT SHOULD I EXPECT?
The purpose of this research study is to assess the safety, tolerability, and efficacy of Atogepant compared to placebo for the prevention of migraine in participants who previously failed oral preventative medications. There will be 8 scheduled clinic visits. The double-blind treatment period will last 12 weeks, with a safety follow-up period of 4 additional weeks. Participants will be given the option to roll over into a long-term safety extension study. For these rollover participants the follow-up visit will be performed in the long-term safety extension study. If you qualify and choose to volunteer, we would provide the investigational study drug, as well as all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, and urine drug/pregnancy tests). You may be compensated for your time and effort. Total duration of study participation for one participant is approximately 20 weeks.
TO FIND OUT MORE
LEARN MORE ABOUT OUR STUDIES
Clinvest Research is a clinical investigation company based in southwest Missouri. We are constantly seeking participants for clinical trials in order to further options for sufferers of various conditions. Our doctors are a part of a select group of clinics in the U.S. that have been involved in over 200 Phase II-IV clinical research studies sponsored primarily by the pharmaceutical industry or studies created by doctors after patient observation.
Study visits are conducted via outpatient and do not require overnight stays. In fact, we pride ourselves in making your participation in the studies as easy and convenient as possible.
If you qualify and choose to join a study, you will be treated by our team of specialists and may receive study-related care at no cost. Call us at (417) 883-7889 to learn more.